Measured Wealth Private Client Group’s Zimmer Biomet ZBH Stock Holding History

Measured Wealth Private Client Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86	Hold	1	–	–	﹤0.01%	673
2026 Q1	$90	Hold	1	–	–	﹤0.01%	672
2025 Q4	$90	Hold	1	–	–	﹤0.01%	698
2025 Q3	$99	Buy	+1	New	+$99	﹤0.01%	671
2018 Q4	–	Sell	-958	Closed	-$123K	–	730
2018 Q3	$123K	Buy	+958	New	+$114K	0.07%	206

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Measured Wealth Private Client Group's ZBH Position: Q2 2026 in Review

Measured Wealth Private Client Group held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 1 share worth $86. The position accounts for ﹤0.01% of the portfolio, ranked #673.

Measured Wealth Private Client Group first reported a position in ZBH in Q3 2018 and has held it in 5 quarters since. The position peaked at $123K in Q3 2018. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Measured Wealth Private Client Group held 1 share of Zimmer Biomet worth $86 as of Q2 2026.
Measured Wealth Private Client Group left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #673 holding.
Measured Wealth Private Client Group first reported a position in Zimmer Biomet in Q3 2018 and has held it in 5 quarters since.
Measured Wealth Private Client Group's Zimmer Biomet position peaked at $123K in Q3 2018.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.